no code implementations • 25 Sep 2023 • Alyssa M. Vanderbeek, Anna A. Vidovszky, Jessica L. Ross, Arman Sabbaghi, Jonathan R. Walsh, Charles K. Fisher, the Critical Path for Alzheimer's Disease, the Alzheimer's Disease Neuroimaging Initiative, the European Prevention of Alzheimer's Disease, Consortium, the Alzheimer's Disease Cooperative Study
A crucial task for a randomized controlled trial (RCT) is to specify a statistical method that can yield an efficient estimator and powerful test for the treatment effect.
no code implementations • 18 Jan 2023 • Monica H. Wojcik, Chloe M. Reuter, Shruti Marwaha, Medhat Mahmoud, Michael H. Duyzend, Hayk Barseghyan, Bo Yuan, Philip M. Boone, Emily E. Groopman, Emmanuèle C. Délot, Deepti Jain, Alba Sanchis-Juan, Genomics Research to Elucidate the Genetics of Rare Diseases, Consortium, Lea M. Starita, Michael Talkowski, Stephen B. Montgomery, Michael J. Bamshad, Jessica X. Chong, Matthew T. Wheeler, Seth I. Berger, Anne O'Donnell-Luria, Fritz J. Sedlazeck, Danny E. Miller
Despite advances in clinical genetic testing, including the introduction of exome sequencing (ES), more than 50% of individuals with a suspected Mendelian condition lack a precise molecular diagnosis.